Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy

S Gujar, JG Pol, V Kumar, M Lizarralde-Guerrero… - Nature …, 2024 - nature.com
… lyse cancer cells through a mechanism known as ‘oncolysis’ or indirectly target cancer cells
… In the latter case, multiple effector/cytotoxic activities of both the innate and adaptive arms of …

Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer

KK Zarrabi, V Narayan, PJ Mille… - Therapeutic …, 2023 - journals.sagepub.com
… focus on direct T-cell activation as a target for cellular … ), and post-treatment tumor biopsy
demonstrated infiltration by P-… BiTE-expressing oncolytic adenoviruses with CAR T-cell therapy …

Oncolytic virotherapy: Challenges and solutions

NH Goradel, AT Baker, A Arashkia, N Ebrahimi… - … problems in cancer, 2021 - Elsevier
… to create cancer selectivity of oncolytic adenoviruses. Small … Repetitive biopsies from patients
treated with GL-ONC1 … , insertion of single-chain T-cell receptors, and modifications on the …

[引用][C] Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies. EMBO Mol Med 9 (8): 1067–1087

JD Freedman, J Hagel, EM Scott, I Psallidas, A Gupta… - 2017

Preclinical evaluation of the gorilla‐derived HAdV‐B AdV‐lumc007 oncolytic adenovirus 'GoraVir'for the treatment of pancreatic ductal adenocarcinoma

STF Bots, TJ Harryvan, C Groeneveldt… - … Oncology, 2023 - Wiley Online Library
… Center from a single fineneedle biopsy [14] conform the … the incorporation of a bispecific
T-cell engager directed at FAP [… Finally, we addressed whether the superior cytotoxicity of …

Use of liquid patient ascites fluids as a preclinical model for oncolytic virus activity

EM Scott, S Frost, H Khalique, JD Freedman… - Oncolytic Viruses, 2020 - Springer
… this or any other protocol involving human biopsies. … Oncolytic Adenovirus Here, we describe
an experiment using an EpCAM-targeted bispecific T cell engager delivered by an oncolytic

Combination IFNβ and membrane-stable CD40L maximize tumor dendritic cell activation and lymph node trafficking to elicit systemic T-cell immunity

H Zheng, X Yu, ML Ibrahim, D Foresman, M Xie… - Cancer immunology …, 2023 - AACR
… An oncolytic adenovirus (MEM-288) expressing MEM40 + … to the TME without causing
systemic toxicity. Herein, we report … Genomic DNA of biopsy tissue or PBMCs was isolated using …

Patient-derived organoids for precision cancer immunotherapy

M Grönholm, M Feodoroff, G Antignani, B Martins… - Cancer research, 2021 - AACR
… for the sensitivity to oncolytic adenovirus therapy alone or in … HER2 derived from
patient biopsies were cultured in Matrigel … the CAR T cell by a bystander effect of CAR T-cell–derived …

Oncolytic viruses: priming time for cancer immunotherapy

L Russell, KW Peng, SJ Russell, RM Diaz - BioDrugs, 2019 - Springer
… , oncolytic adenoviruses expressing bispecific T cell engagers have shown to effectively target
… This includes the use of anti-cytotoxic T cell lymphocyte antigen 4 (CTLA4) antibodies and …

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

JP Machiels, R Salazar, S Rottey, I Duran… - … of cancer, 2019 - Springer
… has potent and tumor-selective cytotoxicity, inducing a non-… who had abdominal wall
metastases biopsied 39 days after the … One example is the expression of a bispecific T-cell